REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2021

Sep 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
CIK: 0000872589
Period of Report: 2021-09-01

Reporting Person: RYAN ARTHUR F (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-01	Common Stock	S	10	$672.75	Disposed	23381	Direct
2021-09-01	Common Stock	S	19	$673.56	Disposed	23362	Direct
2021-09-01	Common Stock	S	14	$674.51	Disposed	23348	Direct
2021-09-01	Common Stock	S	7	$675.7	Disposed	23341	Direct
2021-09-01	Common Stock	S	21	$676.54	Disposed	23320	Direct
2021-09-01	Common Stock	S	3	$677.7	Disposed	23317	Direct
2021-09-01	Common Stock	S	10	$678.43	Disposed	23307	Direct
2021-09-01	Common Stock	S	3	$679.55	Disposed	23304	Direct
2021-09-01	Common Stock	S	4	$680.53	Disposed	23300	Direct
2021-09-01	Common Stock	S	2	$681.48	Disposed	23298	Direct
2021-09-01	Common Stock	S	4	$682.32	Disposed	23294	Direct
2021-09-01	Common Stock	S	1	$683.79	Disposed	23293	Direct
2021-09-01	Common Stock	S	2	$684.31	Disposed	23291	Direct

Footnotes

F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2: Represents volume-weighted average price of sales of 10 shares of Company stock on September 1, 2021 at prices ranging from $672.18 to $672.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 1, 2021 at each separate price.

F3: Represents volume-weighted average price of sales of 19 shares of Company stock on September 1, 2021 at prices ranging from $673.01 to $673.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 1, 2021 at each separate price.

F4: Represents volume-weighted average price of sales of 14 shares of Company stock on September 1, 2021 at prices ranging from $674.06 to $674.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 1, 2021 at each separate price.

F5: Represents volume-weighted average price of sales of 7 shares of Company stock on September 1, 2021 at prices ranging from $675.01 to $675.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 1, 2021 at each separate price.

F6: Represents volume-weighted average price of sales of 21 shares of Company stock on September 1, 2021 at prices ranging from $676.23 to $676.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 1, 2021 at each separate price.

F7: Represents volume-weighted average price of sales of 3 shares of Company stock on September 1, 2021 at prices ranging from $677.60 to $677.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 1, 2021 at each separate price.

F8: Represents volume-weighted average price of sales of 10 shares of Company stock on September 1, 2021 at prices ranging from $678.00 to $678.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 1, 2021 at each separate price.

F9: Represents volume-weighted average price of sales of 3 shares of Company stock on September 1, 2021 at prices ranging from $679.04 to $679.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 1, 2021 at each separate price.

F10: Represents volume-weighted average price of sales of 4 shares of Company stock on September 1, 2021 at prices ranging from $680.00 to $680.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 1, 2021 at each separate price.

F11: Represents volume-weighted average price of sales of 2 shares of Company stock on September 1, 2021 at prices ranging from $681.02 to $681.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 1, 2021 at each separate price.

F12: Represents volume-weighted average price of sales of 4 shares of Company stock on September 1, 2021 at prices ranging from $682.28 to $682.36. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 1, 2021 at each separate price.

F13: Represents volume-weighted average price of sales of 2 shares of Company stock on September 1, 2021 at prices ranging from $684.31 to $684.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 1, 2021 at each separate price.